Please login to the form below

Not currently logged in
Email:
Password:

Evotec CEO Werner Lanthaler temporarily stands down

Cites health reasons

Evotec's CEO Dr Werner Lanthaler, has temporarily stood down from his role within the company due to health reasons.

Dr Lanthaler informed the supervisory board of his situation, and the board approved approved his leave of absence. It also wished Dr Lanthaler an early recovery.

The management board of Dr Cord Dohrmann and Colin Bond, under the direction of Dr Mario Polywka, the chief operating officer, will lead the company in the absence of Dr Lanthaler.

He will reassume the role of CEO as soon as he has recovered.

5th October 2012

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Double Helix

Double Helix is an independent healthcare consultancy with headquarters in London and offices in the US and Singapore. Established in...

Latest intelligence

Business as usual
MHRA explains that its emphasis will remain firmly on vetting when it comes to pharma advertising...
How to get management buy-in for content marketing
Pharma content marketing is still fairly new in the scheme of things for the pharma industry. In the conservative and traditional pharma industry that’s fraught with regulations, getting management buy-in...
EY Life Sciences Sector Update
Asia-Pacific and Japan...

Infographics